Your browser doesn't support javascript.
loading
Glycaemic control and microvascular complications among paediatric type 2 diabetes mellitus patients in Hong Kong at 2 years after diagnosis.
Yam, W I; Wong, S M Y; Cheung, P T; Kwan, E Y W; Lam, Y Y; Wong, L M; Ng, K L; Wong, S W C; Lee, C Y; Tay, M K; Chan, K T; Fu, A C C; Tung, J Y L; Pang, G S W; Yau, H C; See, Q W S; Lo, P W C; To, S W Y; Yuen, H W; Chung, J Y K; Wong, E W Y; Poon, S W Y; Lam, C H Y; Chan, S S Y; Tsui, J H C; Chan, C S Y; But, B W M.
Afiliación
  • Yam WI; Department of Paediatrics, Queen Elizabeth Hospital, Hong Kong SAR, China.
  • Wong SMY; Department of Paediatrics, Queen Elizabeth Hospital, Hong Kong SAR, China.
  • Cheung PT; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Kwan EYW; Department of Paediatrics and Adolescent Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
  • Lam YY; Department of Paediatrics and Adolescent Medicine, Kwong Wah Hospital, Hong Kong SAR, China.
  • Wong LM; Department of Paediatrics and Adolescent Medicine, Tuen Mun Hospital, Hong Kong SAR, China.
  • Ng KL; Department of Paediatrics and Adolescent Medicine, United Christian Hospital, Hong Kong SAR, China.
  • Wong SWC; Department of Paediatrics and Adolescent Medicine, Alice Ho Miu Ling Nethersole Hospital, Hong Kong SAR, China.
  • Lee CY; Department of Paediatrics, Caritas Medical Centre, Hong Kong SAR, China.
  • Tay MK; Department of Paediatrics, Tseung Kwan O Hospital, Hong Kong SAR, China.
  • Chan KT; Department of Paediatrics and Adolescent Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
  • Fu ACC; Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong SAR, China.
  • Tung JYL; Department of Paediatrics, Hong Kong Children's Hospital, Hong Kong SAR, China.
  • Pang GSW; Department of Paediatrics, Hong Kong Children's Hospital, Hong Kong SAR, China.
  • Yau HC; Department of Paediatrics, Prince of Wales Hospital, Hong Kong SAR, China.
  • See QWS; Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
  • Lo PWC; Department of Paediatrics and Adolescent Medicine, United Christian Hospital, Hong Kong SAR, China.
  • To SWY; Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong SAR, China.
  • Yuen HW; Department of Paediatrics and Adolescent Medicine, Kwong Wah Hospital, Hong Kong SAR, China.
  • Chung JYK; Department of Paediatrics, Caritas Medical Centre, Hong Kong SAR, China.
  • Wong EWY; Department of Paediatrics and Adolescent Medicine, Tuen Mun Hospital, Hong Kong SAR, China.
  • Poon SWY; Department of Paediatrics, Hong Kong Children's Hospital, Hong Kong SAR, China.
  • Lam CHY; Department of Paediatrics and Adolescent Medicine, Alice Ho Miu Ling Nethersole Hospital, Hong Kong SAR, China.
  • Chan SSY; Department of Paediatrics, Prince of Wales Hospital, Hong Kong SAR, China.
  • Tsui JHC; Department of Paediatrics and Adolescent Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong SAR, China.
  • Chan CSY; Department of Paediatrics, Tseung Kwan O Hospital, Hong Kong SAR, China.
  • But BWM; Department of Paediatrics, Queen Elizabeth Hospital, Hong Kong SAR, China.
Hong Kong Med J ; 2024 Aug 16.
Article en En | MEDLINE | ID: mdl-39147587
ABSTRACT

INTRODUCTION:

Type 2 diabetes mellitus (T2DM) is becoming increasingly common among children and adolescents worldwide, including those in Hong Kong. This study analysed the characteristics and prevalence of microvascular complications among paediatric T2DM patients in Hong Kong at diagnosis and 2 years after diagnosis.

METHODS:

All patients aged <18 years who had been diagnosed with DM at public hospitals in Hong Kong were recruited into the Hong Kong Childhood Diabetes Registry. Data collected at diagnosis and 2 years after diagnosis were retrospectively retrieved from the Registry for patients diagnosed from 2014 to 2018.

RESULTS:

Median haemoglobin A1c (HbA1c) levels were 7.5% (n=203) at diagnosis and 6.5% (n=135) 2 years after diagnosis; 59.3% of patients achieved optimal glycaemic control (HbA1c level <7%) at 2 years. A higher HbA1c level at diagnosis was associated with worse glycaemic control at 2 years (correlation coefficient=0.39; P<0.001). The presence of dyslipidaemia (adjusted odds ratio [aOR]=3.19; P=0.033) and fatty liver (aOR=2.50; P=0.021) at 2 years were associated with suboptimal glycaemic control. Diabetic neuropathy and retinopathy were rare in our cohort, but 18.6% of patients developed microalbuminuria (MA) within 2 years after diagnosis. Patients with MA had a higher HbA1c level at 2 years (median 7.2% vs 6.4%; P=0.037). Hypertension was a risk factor for MA at 2 years, independent of glycaemic control (aOR=4.61; P=0.008).

CONCLUSION:

These results highlight the importance of early diagnosis and holistic management (including co-morbidity management) for paediatric T2DM patients.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Hong Kong Med J Asunto de la revista: MEDICINA Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Hong Kong Med J Asunto de la revista: MEDICINA Año: 2024 Tipo del documento: Article